Free Newsletter
J&J agrees to pay $785M for surgery tech firm
Free newsletter via e-mail
Tools
Johnson & Johnson, in the latest of a string of significant deals this year, said it would pay $785 million in cash to acquire privately held Acclarent and its sinus-surgery technology. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: